(2R,3S,4S,5S,6R)-6-[[(2R,3S,4S,5S,6R)-4,5-Dihydroxy-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol

Term ID

CHEBI:149115

Synonyms

beta-D-manno-hexopyranosyl-(1->2)-[beta-D-manno-hexopyranosyl-(1->6)]-beta-D-manno-hexopyranosyl-(1->6)-beta-D-manno-hexopyranose
Man(b1-2)[Man(b1-6)]Man(b1-6)b-Man
WURCS=2.0/1,4,3/[a1122h-1b_1-5]/1-1-1-1/a6-b1_b2-c1_b6-d1

Definition

References

GlyGen:G28174GA
GlyTouCan:G28174GA

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2R,3S,4S,5S,6R)-6-[[(2R,3S,4S,5S,6R)-4,5-Dihydroxy-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol

Phenotype where environments contain (2R,3S,4S,5S,6R)-6-[[(2R,3S,4S,5S,6R)-4,5-Dihydroxy-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol

Phenotype modified by environments containing (2R,3S,4S,5S,6R)-6-[[(2R,3S,4S,5S,6R)-4,5-Dihydroxy-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol

Phenotype affecting (2R,3S,4S,5S,6R)-6-[[(2R,3S,4S,5S,6R)-4,5-Dihydroxy-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol

Human Disease Model